Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation

The present invention relates to aromatic organic compounds which are specific, potent and safe inhibitors of the Ca -activated potassium channel (Gardos channel) of erythrocytes and/or of mammalian cell proliferation. The compounds can be used to reduce sickle erythrocyte dehydration and/or delay t...

Full description

Saved in:
Bibliographic Details
Main Authors Brugnara, Carlo, Halperin, Jose, Fluckiger, Rudolf, Bellott, Jr., Emile M, Lombardy, Richard John, Clifford, John J, Gao, Ying-Duo, Haidar, Reem M, Kelleher, Eugene W, Moussa, Adel M, Sachdeva, Yesh P, Sun, Minghua, Taft, Heather N
Format Patent
LanguageEnglish
Published 05.10.2004
Online AccessGet full text

Cover

Abstract The present invention relates to aromatic organic compounds which are specific, potent and safe inhibitors of the Ca -activated potassium channel (Gardos channel) of erythrocytes and/or of mammalian cell proliferation. The compounds can be used to reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation in situ as a therapeutic approach towards the treatment or prevention of sickle cell disease. The compounds can also be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation. The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.
AbstractList The present invention relates to aromatic organic compounds which are specific, potent and safe inhibitors of the Ca -activated potassium channel (Gardos channel) of erythrocytes and/or of mammalian cell proliferation. The compounds can be used to reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation in situ as a therapeutic approach towards the treatment or prevention of sickle cell disease. The compounds can also be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation. The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.
Author Taft, Heather N
Halperin, Jose
Gao, Ying-Duo
Lombardy, Richard John
Haidar, Reem M
Moussa, Adel M
Clifford, John J
Sachdeva, Yesh P
Fluckiger, Rudolf
Bellott, Jr., Emile M
Kelleher, Eugene W
Brugnara, Carlo
Sun, Minghua
Author_xml – sequence: 1
  fullname: Brugnara, Carlo
– sequence: 2
  fullname: Halperin, Jose
– sequence: 3
  fullname: Fluckiger, Rudolf
– sequence: 4
  fullname: Bellott, Jr., Emile M
– sequence: 5
  fullname: Lombardy, Richard John
– sequence: 6
  fullname: Clifford, John J
– sequence: 7
  fullname: Gao, Ying-Duo
– sequence: 8
  fullname: Haidar, Reem M
– sequence: 9
  fullname: Kelleher, Eugene W
– sequence: 10
  fullname: Moussa, Adel M
– sequence: 11
  fullname: Sachdeva, Yesh P
– sequence: 12
  fullname: Sun, Minghua
– sequence: 13
  fullname: Taft, Heather N
BookMark eNqNjk1KBEEMhXuhi_HnDjmAQoM4zF6U2ete0l2p6YJ00iQpYTyVR7RKPYCr9-W9vJCr4UJUaDd8vdbJo0QNSpDKtpCcGYok7PndLxGgpI7KBLOum1ZJ_mOiIOupkkMsZKQZqlOuDFmtWxBGGCtJQMs2o4-GRaVPqTiht-q8oOEcZOWzfTGdASdRW5FhJubWUi6ZDHvxZrjMyE63f3o9wMvz29PxvvqG0Y77-8mwy7g_jOP-8fDwj5VvVOpfIQ
ContentType Patent
CorporateAuthor Nuchem Pharmaceuticals, Inc
President & Fellows of Harvard College
Children's Medical Center Corporation
CorporateAuthor_xml – name: President & Fellows of Harvard College
– name: Nuchem Pharmaceuticals, Inc
– name: Children's Medical Center Corporation
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 06800658
GroupedDBID EFH
ID FETCH-uspatents_grants_068006583
IEDL.DBID EFH
IngestDate Sun Mar 05 22:30:37 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_068006583
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6800658
ParticipantIDs uspatents_grants_06800658
PatentNumber 6800658
PublicationCentury 2000
PublicationDate 20041005
PublicationDateYYYYMMDD 2004-10-05
PublicationDate_xml – month: 10
  year: 2004
  text: 20041005
  day: 05
PublicationDecade 2000
PublicationYear 2004
References Brugnara, C., et al., "Inhibition of Gardos Channel and Red Cell Dehydration by Oral Administration of Clotrimazole in Sickle Cell Disease," Blood, 220a:865 (1994).
Pappas, J. B., et al., "Hepatic Clotrimazole Concentrations and Hepatic Drug Metabolizing Enzyme Activities in Adult Mail Sprague-Dawley Rats," Toxicology, 80:27-35 (1993).
Bergman, J., et al., "Synthesis and Studies of Tris-Indolobenzenes and Related Compounds," Tetrahedron, 36:1445-1450 (1980).
Gait, M. J., "An Introduction to Modern Methods of DNA Synthesis," Introduction to DNA Synthesis, 1:1-22.
Hoogerheide, J. G., et al., "Clotrimazole," Analytical Profiles of Drug Substances, 11:225-255 (1982).
Enokida et al., Chem. Abstract 126:39836, 1996.
Wyche, J. H., et al., "Growth Regulation of Cultured Human Pituitary Cells by Steroidal and Nonsteroidal Compounds in Defined Medium," Endocrinology, 104(6):1765-1773 (1979).
Tomioka, K., et al., "Highly Stereoselective Construction of Chiral Quarternary Carbon: Asymmetric Synthesis of , -Distributed -Butyrolactones," Chemistry Letters, pp. 1621-1624 (1981).
Stuart, J., et al., "Additive in vitro Effects of Anti-Sickling Drugs," British Journal of Hematology, 86:820-823 (1994).
Dakkourl et al., "Effect of Dielectric Constant and Ionic Strength on the Fading of N, N-Dimethylaminophenolphthalein in Alkaline Medium", Chemical Abstract vol. 126, No. 23, Jun. 9, 1997, J. Chemical Education, 1997 74(5):556-559.
Sakuta, M., et al., "Potent Antitumor Agents with Low Toxicity," Chemical Abstracts, 119:92, col. 2, Abstract No. 63033j (1993).
Conte, L., et al., "Pharmacokinetic Study of [14C]Flutrimazole after Oral and Intravenous Administration in Dogs," Arzneim.-Forsch./Drug Res., 42[I](6):854-858 (1992).
Duchene, P., et al., "Pharmacokinetic Profile of [14C]Flutrimazole Following Single Topical Application in Normal and Scarified Skin of Healthy Volunteers," Arzneim.-Forsch./Drug Res., 42[I](6):861-863 (1992).
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1008, 1996.
Fan, et al., Yiyao Gongye, 9:2-4 (1983).
Ponnuswamy, M. N., et al., "Acetyltriphenylmethane, *C21H18O," Acta Cryst., 40:142-144 (1984).
(0 583 665) 19940200
(483632) 19920500
Ando, W., et al., "A Novel Reduction of -Aryl Alkanols by Diiododimethylsilane," Tetrahedron Letters, 51:4941-4942 (1979).
Peppelenbosch, M. P., et al., "Epidermal Growth Factor-activated Calcium and Potassium Channels," Journal of Biological Chemistry, 266(30):19938-19944 (1991).
Matsuura, Y., et al., "Structure-Activity Relationships in the Induction of Hepatic Microsomal Cytochrome P450 by Clotrimazole and its Structurally Related Compounds in Rats," Biochemical Pharmacology, 41(12):1949-1956 (1991).
Gait, M. J., "Oligonucleotide Synthesis, A Practical Approach," IRL Press, Oxford, pp. 13 and 76 (1984).
(3706427) 19880900
Chun, Moon Woo et al. "Reactivity of 3-Haloindolenines", Chemical Abstracts, vol. 96, No. 17, Apr. 26, 1982, pp. 735.
Bontems, F., et al., "Analysis of Side-Chain Organization on a Refined Model of Charybdotoxin: Structural and Functional Implications," Biochemistry, 31:7756-7764 (1992).
Epstein, R. J., et al., "Corneal Neovascularization," Cornea, 6(4):250-257 (1987).
Starnes, Jr., Chem. Abstract 69:43555, 1968.
(WO 02/32465) 20020400
Chem. Abstr., vol. 81, No. 13, Sep. 30, 1974 (Columbus, OH, USA) p. 448, col. 1, the abstract No. 77766j, Isobe, M. et al. "3H-indole. I. General synthetic route of 3,3-disubstituted 3H-indoles via the corresponding oxindoles and the indolines." Yakugaku Zasshi 1974, 94(3), 343-50 (Japan).
Brugnara, C., et al., "Therapy with Oral Clotrimazole Induces Inhibition of the Gardos Channel and Reduction of Erythrocyte Dehydration in Patients with Sickle Cell Disease," J. Clin. Invest., 97(5):1227-1234 (1996).
Hoch, J. M., et al., "Methode de synthese generale des acetonitriles trisubstitues de la formule generale," Acadamie Des Sciences, 245:73-75 (1957).
Ethridge, D. E., et al., "Economic Weed Control in High Plains Cotton," J. Prod. Agric., 3(2):246-252 (1990).
Liu, M. T. H., et al., "Equilibrium Constants for Triphenylmethyl Bromide and 3-Bromo-3-phenyldiazirine in Acetonitrile." Tetrahedron Letters, 28(33):3763-3766 (1987).
Fleming, I., et al., "Two New Stereochemically Complementary Oxindole Syntheses,"Tetrahedron Letters, 23(19):2053-2056 (1982).
Hendrickson et al., Chem. Abstract No. 110:113878, 1989.
Clark, M. R., et al., "Hydration of Sickle Cells Using the Sodium Ionophore Monensin," J. Clin. Invest., 70:1074-1080 (1982).
(WO 96/36631) 19961100
(WO 96/08242) 19960300
Cushman et al. (5430062) 19950700
(WO 95/26720) 19951000
Vasquez, J., et al., "Characterization of High Affinity Binding Sites for Charybdotoxin in Sarcolemmal Membranes from Bovine Aortic Smooth Muscle," The Journal of Biological Chemistry, 264(35):20902-20909 (1989).
Conte, L., et al., "Percutaneous Absorption and Skin Distribution of [14C]Flutrimazole in Mini-pigs," Arzneim.-Forsch./Drug Res., 42[I](6):847-853 (1992).
O'Donnell, M. J., et al., "Synthesis and Properties of a Hoechst-Like Minor-Groove Binding Agent Tethered to an Oligodeoxynucleotide." Bioorganic & Medicinal Chemistry, 3(6):743-750 (1995).
Ian Fleming et al., "Two New Oxindole Syntheses", J. Chemical Society, 1986, pp. 349-359.
Carter, A.J., et al., "Morphologic Characteristics of Lesion Formation and Time Course of Smooth Muscle Cell Proliferation in a Porcine Proliferative Restenosis Model," JACC, 24(5):1398-1405 (1994).
Trudel, M., et al., "Towards a Transgenic Mouse Model of Sickle Cell Disease: Hemoglobin SAD," The EMBO Journal, 10(11):3157-3165 (1991).
Park, C., et al., "Design, Synthesis, and Functional Expression of a Gene for Charybdotoxin, a Peptide Blocker of K+ Channels," Proc. Natl. Acad. Sci. USA, 88:2046-2050 (1991).
Zhu, B., et al., "Effects of Etidronate and Lovastatin on the Regression of Artherosclerosis in Cholesterol-Fed Rabbits," Cardiology, 85:370-377 (1994).
Chem. Abstr., vol. 109, No. 19, Nov. 7, 1988 (Columbus, OH, USA) p. 696, col. 2, the abstract No. 170175x, Nishio, T. et al. "A novel route to indolines by photochemical desulfurization of indoline-2-thiones." J. Chem. Soc. Commun. 1988, (9), 572-3 (Eng).
Corbett, T. H., "Preclinical Anticancer Activity of Cryptophycin-8," Journal of Experimental Therapeutics & Oncology, 1:95-108 (1996).
Burgess, M.A., et al., Clotrimazole (Bay b 5097): In Vitro and Clinical Pharmacological Studies Antimicrobial Agents and Chemotherapy, 2(6):423-426 (1972).
(0 323 740) 19890700
Owens, N. J., et al., "Prophylaxis of Oral Candidiasis with Clotrimazole Troches," Arch. Intern. Med., 144:290-293 (1984).
Rosa, R. M., et al., "A Study of Induced Hyponatremia in the Prevention and Treatment of Sickle-Cell Crisis," The New England Journal of Medicine, 303(20):1138-1143 (1980).
Bartroli, J., et al., "Synthesis and Antifungal Activity of a Series of Difluorotritylimidazoles." Arzneim.-Forsch./Drug Res., 42[I]6:832-835 (1992).
Charache, S., et al., "Effect of Hydroxyurea on the Frequency of Painful Crisis in Sickle Cell Anemia," The New England Journal of Medicine, 332(20):1317-1322 (1995).
Sasakura et al., Synthesis of 11-phenyl-5,6-dihydro-11H-dibenz(b,e)elazepine derivatives. Heterocycles, vol. 15, No. 1, pp. 421-425, 1981.
Barili et al., Chem. Abstract 107:58774, 1987.
Fahim, M., et al., "Cardiovascular Effects and Pharmacokinetics of the Carboxylic Ionophore Monensin in Dogs and Rabbits," Life Sciences, 29:1959-1966 (1981).
Holt, R. J., "Laboratory Assessment of the Antimycotic Drug Clotrimazole," J. Clin. Path., 25:1089-1097 (1972).
Nishio, T., et al., "A Novel Route to Indolines by Photochemical Desulphurization of Indoline-2-thiones," J. Chem. Soc., Chem. Commun., 9:572-573 (1988).
Ritter, W., "Pharmacokinetic Fundamentals of Vaginal Treatment with Clotrimazole," Am. J. Obster. Gynecol., 152(7 part 2):945-947 (1985).
Hanessian, S., et al., "Ethers and Anhydrosugars," Methods Carbohydr. Chem., 7:63-67 (1976).
(0 636 608) 19950200
Starnes, Chem. Abstract 69:43555, 1968.
Lewis, T. W., et al., "Solid State Dehydration of (o-Hydroxyaryl)diphenylmethanols. Crystal and Molecular Structures of [I-(2-Hydroxyphenyl)]diphenylmethanol and of [I-(2-Hydroxynaphthyl)]diphenylmethanol," J. Am. Chem. Soc., 102:4659-4664 (1980).
Bergman, J., et al., "Synthesis and Studies of Tris-Indolobenzenes and Related Compounds," Chemical Abstracts, 94:368. Col. 1, Abstract No. 3948s (1981).
(05050771) 19930300
Ferguson, G., et al., "The Structure of Triphenylgermanium Hydroxide," Acta Cryst., 48: 1228-1231 (1992).
Brugnara et al. (2002/0128256) 20020900
(WO 99/26624) 19990600
Brugnara et al. (5273992) 19931200
Gagnon, Beilstein No. 4924895, 1929.
Gagnon, Beilstein Reg. No. 4924895, 1929.
Omenn, Cancer Prevention, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1008-1010, 1996.
L.L. Miller et al., "The Thermolysis of Substituted Indenes. Sigmatropic Phenyl and Hydrogen Migrations," J. of American Chemical Society, 93:3, Feb. 10, 1971, pp. 650-656.
Stuart, J., et al., "Oxpentifylling and Cetiedil Citrate Improve Deformability of Dehydrated Sickle Cells," Journal of Clinical Pathology, 40(10):1182-1186 (1987).
Paoletti, P., et al., "Drugs Acting on Brain Tumor Sterols," The Experimental Biology of Brain Tumors, pp. 457-479 (1972).
Illes, Z., et al., "Application of Modified Silica Gels in the Pesticide Analysis II. Thin-Layer Chromatography of Benzonitrile and Triphenylmethane Derivatives," Acta Phytopathologica et Entomologica Hungarica, 23(1-2):243-255 (1988).
Sawyer, P. R., et al., "Clotrimazole: A Review of its Antifungal Activity and Therapeutic Efficacy." Drugs, 9:424-447 (1975).
Perrine, S. P., et al., "A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the -Globin Disorders," The New England Journal of Medicine, 328(2):81-86 (1993).
Omenn, Cancer Prevention, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 1008-1010, 1996.
(WO 96/08240) 19960300
McLaughlin et al. (4006023) 19770200
Isobe, M., et al., "General Synthetic Route of 3,3-Disubstituted 3H-Indoles
References_xml – year: 19880900
  ident: 3706427
– year: 19950200
  ident: 0 636 608
– year: 19890200
  ident: 4806685
  contributor:
    fullname: Abraham et al.
– year: 19770200
  ident: 4006023
  contributor:
    fullname: McLaughlin et al.
– year: 19960300
  ident: WO 96/08240
– year: 19960400
  ident: 5512563
  contributor:
    fullname: Albright et al.
– year: 19890900
  ident: WO 89/08096
– year: 19701200
  ident: 3546165
  contributor:
    fullname: Morgan
– year: 19941000
  ident: 5358959
  contributor:
    fullname: Halperin et al.
– year: 20010800
  ident: 10004654
– year: 19890700
  ident: 0 323 740
– year: 19940200
  ident: 0 583 665
– year: 19990600
  ident: WO 99/26624
– year: 19920500
  ident: 483632
– year: 19930300
  ident: 05050771
– year: 19960300
  ident: WO 96/08242
– year: 19931200
  ident: 5273992
  contributor:
    fullname: Brugnara et al.
– year: 20020900
  ident: 2002/0128256
  contributor:
    fullname: Brugnara et al.
– year: 20020400
  ident: WO 02/32465
– year: 19950700
  ident: 5430062
  contributor:
    fullname: Cushman et al.
– year: 19930300
  ident: 05 58894
– year: 19910100
  ident: 4988785
  contributor:
    fullname: Paul et al.
– year: 19961100
  ident: WO 96/36631
– year: 19951000
  ident: WO 95/26720
Score 2.6088417
Snippet The present invention relates to aromatic organic compounds which are specific, potent and safe inhibitors of the Ca -activated potassium channel (Gardos...
SourceID uspatents
SourceType Open Access Repository
Title Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6800658
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8QwEB12F0E9KSquX8zBo9Va2233LFuKoOxBYW9L0iYi1HTZtCzrr_InOpOW4kVv6YSGfJDOm8zrC8D1fayKIC9yTyktvJD5jYmc-l4Y61AK8rDC3dbw_DLJ3sKnRbQYQNb_C_NJ28hbUV_sbWNXdeXIlfR5bxfea8WfWSPQsPrAxpSVKOaFvpskzpsOYZj4TO2apdk-7FITBNlMbX85jfQAdubOeggDZY7gm_dom5gvsPhgbtW2RA6JKQJXN21JIUX2XKxKhUz35luPrDMK056zWGTMpiqNjVW6KZFgJ5uw54wj1a06aabK8FOXhrGY9_rMX9QLuUUhDaPWEvkEn96qSua6uOU6Bkxnr4-Z1w9v-b5m2szS76bh4QRG3PlTwIgAXqKDaRQQOiN_T2Ej-UVBME9KqWI9hvGfzZz9U3cOe63oISfTL2BUrxt1SQ66lldu9n8ADrOiUg
link.rule.ids 230,309,786,808,891,64396
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB2VglhOIECUdQ4cCZSQdDlDo7BVPYDUW2Q3NkIKTlUnQuWr-ERmnCjiAjfHVqxxHOe98byMAc6v-yr1Z-nMU0oLL2B940AOu17Q14EUhLDCndbwPO7Fr8HDNJy2IG7-hfmgZeTNyRZ7Wdp5kTtxJX3eq4n3quTPnCPQcPaBT5PlIp2k-qo3cGi6AquMsfyuj6J4CzaoEyJtprC_YCPahrWJq92BljK78M2rtArNp5i-s7pqmSE7xeSDq4uqpJB8ey7mmUIWfPO5R9ZVClPttFhk1qZyjaVVusyQiCdXYaMaR2qb18mZcsNXdSDG4qzJ0PxFVsglCmmYt2bIe_h0V56x2sVN2B5gNHq5jb1meMnbgoUzSbd-EDf70GbjDwBDongD7Q9Dn_gZIT45joSMgoielFL1dQc6f3Zz-E_bGaxP7qLk6X78eASbVQZEjqwfQ7tYlOqE0LqQp24ifgAdxKVO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+diphenyl+indanone%2C+indane+and+indole+compounds+and+analogues+thereof+useful+for+the+treatment+of+prevention+of+diseases+characterized+by+abnormal+cell+proliferation&rft.inventor=Brugnara%2C+Carlo&rft.inventor=Halperin%2C+Jose&rft.inventor=Fluckiger%2C+Rudolf&rft.inventor=Bellott%2C+Jr.%2C+Emile+M&rft.inventor=Lombardy%2C+Richard+John&rft.inventor=Clifford%2C+John+J&rft.inventor=Gao%2C+Ying-Duo&rft.inventor=Haidar%2C+Reem+M&rft.inventor=Kelleher%2C+Eugene+W&rft.inventor=Moussa%2C+Adel+M&rft.inventor=Sachdeva%2C+Yesh+P&rft.inventor=Sun%2C+Minghua&rft.inventor=Taft%2C+Heather+N&rft.number=6800658&rft.date=2004-10-05&rft.externalDBID=n%2Fa&rft.externalDocID=06800658